Lenz Therapeutics, Inc. · NASDAQ:LENZ
Squarepoint Ops LLC reported a 5.10% stake in Lenz Therapeutics, Inc. (Schedule 13G)
Event Apr 1, 2026 · Filed Apr 8, 2026
Squarepoint Ops LLC reported a 5.10% stake in Lenz Therapeutics, Inc., 1,593,246 shares, as a passive investor on Apr 1, 2026. Filed Apr 8, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 1,593,246
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Squarepoint Ops LLC | 5.10% | 1,593,246 |
| Squarepoint Capital LLP | 5.10% | 1,593,246 |
| Squarepoint Operations Private Limited | 5.10% | 1,593,246 |
| Squarepoint (DIFC) Ltd | 5.10% | 1,593,246 |
| Squarepoint Master Fund Limited | 5.10% | 1,590,333 |
| Squarepoint Core Master Fund Limited | 0% | 2,913 |
Source
Related
- Lenz Therapeutics, Inc.
- Squarepoint Ops LLC
- Lenz Therapeutics, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Oct 21, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Schedule 13G · Millennium Management LLC · Jun 26, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G/A · Ridgeback Capital Investments L.P. · Feb 17, 2026